Cancer pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients at least 18 years old; of both sexes; who have neuropathic cancer pain assessed by the Questionnaire for the Diagnosis of Neuropathic Pain (DN-4), Nociceptive or Mixed, with pain intensity classified by Scale Visual Numerical greater than or equal to 4; who make chronic use of morphine, characterized as use more than three months ago
Exclusion criteria
Exclusion criteria: Patients who present inability to communicate verbal or cognitive inability to perform Transcutaneous Electrical Nerve Stimulation (TENS) and non-tolerance within the time proposed therapy; patients with cardiac conditions such as cardiac pacemakers and cardiac arrhythmias; metallic implants at the site of electrode placement; epilepsy; dermatologic conditions, or skin lesions at the location of the pain that makes it impossible to attach the electrode and history of allergies to conductive gel componentes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the effect of high-frequency and low-frequency Transcutaneous Electrical Nerve Stimulation on pain control oncology of patients in palliative care with chronic use of morphine | — |
Secondary
| Measure | Time frame |
|---|---|
| Characterize the profile of patients with cancer pain in palliative care in chronic morphine use;Compare the intensity and aspects of pain in the pre- and post-intervention moments between the groups that will receive high and low frequency Transcutaneous Electrical Nerve Stimulation;Correlate morphine dosage and rescues in the pre and post moments intervention between the groups that will receive high and low frequency Transcutaneous Electrical Nerve Stimulation | — |
Countries
Brazil
Contacts
Universidade Federal do Triângulo Mineiro